114 related articles for article (PubMed ID: 25038068)
21. Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database.
Phongsamart W; Hansudewechakul R; Bunupuradah T; Klinbuayaem V; Teeraananchai S; Prasithsirikul W; Kerr SJ; Akarathum N; Denjunta S; Ananworanich J; Chokephaibulkit K
Int J Infect Dis; 2014 May; 22():19-24. PubMed ID: 24576843
[TBL] [Abstract][Full Text] [Related]
22. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
23. Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study.
Harouna AM; Amorissani-Folquet M; Eboua FT; Desmonde S; N'Gbeche S; Aka EA; Kouadio K; Kouacou B; Malateste K; Bosse-Amani C; Ahuatchi Coffie P; Leroy V;
BMC Infect Dis; 2015 Aug; 15():317. PubMed ID: 26248711
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
25. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire.
Fassinou P; Elenga N; Rouet F; Laguide R; Kouakoussui KA; Timite M; Blanche S; Msellati P
AIDS; 2004 Sep; 18(14):1905-13. PubMed ID: 15353976
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults.
Minga AK; Anglaret X; d' Aquin Toni T; Chaix ML; Dohoun L; Abo Y; Coulibaly A; Duvignac J; Gabillard D; Rouet F; Rouzioux C
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):350-4. PubMed ID: 18545149
[TBL] [Abstract][Full Text] [Related]
27. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.
Desmonde S; Coffie P; Aka E; Amani-Bosse C; Messou E; Dabis F; Alioum A; Ciaranello A; Leroy V
BMC Infect Dis; 2011 Jun; 11():182. PubMed ID: 21699728
[TBL] [Abstract][Full Text] [Related]
28. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens.
Kiselinova M; Geretti AM; Malatinkova E; Vervisch K; Beloukas A; Messiaen P; Bonczkowski P; Trypsteen W; Callens S; Verhofstede C; De Spiegelaere W; Vandekerckhove L
J Antimicrob Chemother; 2015 Dec; 70(12):3311-6. PubMed ID: 26324076
[TBL] [Abstract][Full Text] [Related]
30. Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.
Seyler C; Adjé-Touré C; Messou E; Dakoury-Dogbo N; Rouet F; Gabillard D; Nolan M; Toure S; Anglaret X
AIDS; 2007 May; 21(9):1157-64. PubMed ID: 17502726
[TBL] [Abstract][Full Text] [Related]
31. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
32. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.
Rouet F; Ekouevi DK; Chaix ML; Burgard M; Inwoley A; Tony TD; Danel C; Anglaret X; Leroy V; Msellati P; Dabis F; Rouzioux C
J Clin Microbiol; 2005 Jun; 43(6):2709-17. PubMed ID: 15956387
[TBL] [Abstract][Full Text] [Related]
33. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
[TBL] [Abstract][Full Text] [Related]
34. Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens.
Sarmati L; Parisi SG; Nicastri E; d'Ettorre G; Andreoni C; Dori L; Gatti F; Montano M; Buonomini AR; Boldrin C; Palù G; Vullo V; Andreoni M
J Med Virol; 2007 Jul; 79(7):880-6. PubMed ID: 17516532
[TBL] [Abstract][Full Text] [Related]
35. Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients.
Briz V; Palladino C; Navarro M; Jiménez de Ory S; González-Tomé M; León J; Núñez-Cuadros E; de José M; Ramos J; Muñoz-Fernández M
HIV Med; 2011 Aug; 12(7):442-6. PubMed ID: 21395964
[TBL] [Abstract][Full Text] [Related]
36. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
37. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
[TBL] [Abstract][Full Text] [Related]
38. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
39. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.
Briz V; León-Leal JA; Palladino C; Moreno-Perez D; de Ory SJ; De José MI; González-Tomé MI; Martín CG; Pocheville I; Ramos JT; Leal M; Muñoz-Fernández MÁ
Pediatr Infect Dis J; 2012 Mar; 31(3):273-7. PubMed ID: 22330165
[TBL] [Abstract][Full Text] [Related]
40. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.
Gianella S; von Wyl V; Fischer M; Niederoest B; Battegay M; Bernasconi E; Cavassini M; Rauch A; Hirschel B; Vernazza P; Weber R; Joos B; Günthard HF;
Antivir Ther; 2011; 16(4):535-45. PubMed ID: 21685541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
